Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Seminars in Thrombosis and Hemostasis

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/S-2003-40967PMID 12888933
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hemostatic alterations in cancer patients

  2005cited by this paper
• Procoagulant activity of gastric, colorectal, and renal cancer is factor VII-dependent

  2004cited by this paper
• Treatment of malignancy by activation of the plasminogen system.

  2002cited by this paper
• Angiogenesis as a target for gastric cancer.

  2002cited by this paper
• Extracellular Proteolysis and Angiogenesis

  2001cited by this paper
• The hemostatic system and angiogenesis in malignancy.

  2001cited by this paper
• Localization of Blood Coagulation Factors In Situ in Pancreatic Carcinoma

  2001cited by this paper
• Molecular basis for the relationship between thrombosis and cancer.

  2001cited by this paper
• Tissue Factor as a Therapeutic Target

  2001cited by this paper
• Alteration of haemostasis in non-metastatic gastric cancer.

  2001cited by this paper
• Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation.

  2000cited by this paper
• Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration

  2000cited by this paper
• Fibrinogen and Fibrin Protect Fibroblast Growth Factor-2 from Proteolytic Degradation

  2000cited by this paper
• Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts.

  2000cited by this paper
• Factor XIIIa supports microvascular endothelial cell adhesion and inhibits capillary tube formation in fibrin.

  2000cited by this paper
• Thrombosis in cancer patients.

  2000cited by this paper
• Molecular Biology of the VEGF and the VEGF Receptor Family

  2000cited by this paper
• Expression of prothrombin fragment 1+2 in cancer tissue as an indicator of local activation of blood coagulation.

  2000cited by this paper
• The Role of the Plasminogen Activation System in Cancer

  1999cited by this paper
• Expression of Tissue Factor and Tissue Factor Pathway Inhibitor in situ in Laryngeal Carcinoma

  1999cited by this paper
• On the Mechanism of Thrombin-induced Angiogenesis

  1999cited by this paper
• Pathophysiology of the Thrombophilic State in the Cancer Patient

  1999cited by this paper
• Tissue Factor Signaling

  1999cited by this paper
• Laboratory Diagnosis of the Thrombophilic State in Cancer Patients

  1999cited by this paper
• Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer.

  1999cited by this paper
• Cancer and blood coagulation: molecular aspects.

  1999cited by this paper
• Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor.

  1999cited by this paper
• Vascular endothelial growth factor: molecular and biological aspects.

  1999cited by this paper
• Pentoxifylline Inhibits Hypoxia-induced Upregulation of Tumor Cell Tissue Factor and Vascular Endothelial Growth Factor

  1998cited by this paper
• Profiles of Plasma Serpins in Patients with Advanced Malignant Melanoma, Gastric Cancer and Breast Cancer

  1998cited by this paper
• Tissue Factor Expression and Metastatic Potential of Colorectal Cancer

  1998cited by this paper
• Heparin and Cancer

  1998cited by this paper
• Gastric cancer associated with acute disseminated intravascular coagulation: successful initial treatment with weekly 24‐hour infusion of high‐dose 5‐fluorouracil and leucovorin

  1998cited by this paper
• Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.

  1998cited by this paper
• A Role for Tissue Factor in Cell Adhesion and Migration Mediated by Interaction with Actin-binding Protein 280

  1998cited by this paper
• Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization

  1998cited by this paper
• Diagnostic and prognostic values of plasma levels of fibrinolytic markers in gastric cancer.

  1998cited by this paper
• Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma.

  1997cited by this paper
• High level of urokinase‐type plasminogen activator is a new prognostic marker in patients with gastric carcinoma

  1997cited by this paper
• The prognostic impact of the urokinase-type plasminogen activator system is associated with tumour differentiation in gastric cancer.

  1996cited by this paper
• In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease

  1996cited by this paper
• Prognostic value of the plasminogen activation system in patients with gastric carcinoma

  1996cited by this paper
• Acute disseminated intravascular coagulation syndrome in cancer patients.

  1995cited by this paper
• Usefulness of coagulation markers in staging of gastric cancer.

  1995cited by this paper
• Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

  1995cited by this paper
• Venous tumor thrombosis and cavernous transformation of the portal vein in a patient with gastric carcinoma

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system.

  1995cited by this paper
• Solid tumor cells express functional "tethered ligand" thrombin receptor.

  1995cited by this paper
• Thrombin Induces the Activation of Progelatinase A in Vascular Endothelial Cells

  1995cited by this paper
• Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.

  1994cited by this paper
• Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.

  1994cited by this paper
• Markers of coagulation and fibrinolysis in portal blood from patients with and without gastric malignancy.

  1994cited by this paper
• Distribution of Tissue Factor Pathway Inhibitor in Normal and Malignant Human Tissues

  1993cited by this paper
• Thrombin promotes angiogenesis by a mechanism independent of fibrin formation.

  1993cited by this paper
• Thrombin increases the metastatic potential of tumor cells

  1993cited by this paper
• Tumor cell procoagulant and urokinase expression in carcinoma of the ovary.

  1993cited by this paper
• Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha IIb beta 3 expression on the cell surface.

  1992cited by this paper
• Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues.

  1992cited by this paper
• Acquired factor X deficiency and disseminated intravascular coagulation in a case of metastasizing carcinoma of the stomach and its course under chemotherapy

  1992cited by this paper
• Coagulation Abnormalities in Malignancy: A Review

  1992cited by this paper
• Pathways of Coagulation/Fibrinolysis Activation in Malignancy

  1992cited by this paper
• K-sam-related gene, N-sam, encodes fibroblast growth factor receptor and is expressed in T-lymphocytic tumors.

  1992cited by this paper
• Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain.

  1992cited by this paper
• Tissue factor as a tumor procoagulant

  1992cited by this paper
• Cancer Cell Procoagulants and Their Role in Malignant Disease

  1992cited by this paper
• Successful treatment of Budd-Chiari syndrome with early gastric cancer.

  1991cited by this paper
• Pulmonary embolism as an indicator of occult malignancy.

  1990cited by this paper
• Anticoagulants as cancer therapy.

  1990cited by this paper
• Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers.

  1990cited by this paper
• Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung

  1990cited by this paper
• Fibrinogen-fibrin transformation in situ in renal cell carcinoma.

  1990cited by this paper
• K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes.

  1990cited by this paper
• Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ.

  1990cited by this paper
• Indirect Activation of Blood Coagulation in Colon Cancer

  1989cited by this paper
• High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer.

  1989cited by this paper
• Thrombotic thrombocytopenic purpura associated with metastatic gastric adenocarcinoma: successful management with plasmapheresis.

  1986cited by this paper
• The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining.

  1986cited by this paper
• GROSS and MICROSCOPIC CHARACTERISTICS OF STOMACH CANCER WITH MICROANGIOPATHIC HEMOLYTIC ANEMIA AND/OR DISSEMINATED INTRAVASCULAR COAGULOPATHY

  1985cited by this paper
• Specificity of a monoclonal antibody for the NH2-terminal region of fibrin.

  1984cited by this paper
• A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.

  1983cited by this paper
• Comparison Of 125-I Fibrinogen Kinetics And Fibrinopeptide A In Patients With Disseminated Neoplasias

  1982cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper
• Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma

  1981cited by this paper
• Tumor angiogenesis: therapeutic implications.

  1971cited by this paper

• YTHDF2-mediated m6A modification of ONECUT2 promotes stemness and oxaliplatin resistance in gastric cancer through transcriptionally activating TFPI.

  2025cites this paper
• The Complex Role of Thrombin in Cancer and Metastasis: Focus on Interactions with the Immune System

  2023cites this paper
• Tumor-educated platelets.

  2023cites this paper
• A prognostic gene signature for gastric cancer and the immune infiltration-associated mechanism underlying the signature gene, PLG

  2022cites this paper
• Heterogeneous Expression of Proangiogenic and Coagulation Proteins in Gliomas of Different Histopathological Grade

  2021cites this paper
• Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy

  2021cites this paper
• Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development.

  2021cites this paper
• Features and function of exosomes secreted by heat-stroke vascular endothelial cells

  2020cites this paper
• Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial

  2020cites this paper
• Thrombosis Risk Associated with Head and Neck Cancer: A Review

  2019cites this paper
• Advances on the components of fibrinolytic system in malignant tumors

  2019cites this paper
• Antibody drug conjugates under investigation in phase I and phase II clinical trials for gastrointestinal cancer

  2018cites this paper
• Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma

  2018cites this paper
• Coagulation and fibrinolysis in gastric cancer

  2017cites this paper
• Role of Tissue Factor-FVIIa Blood Coagulation Initiation Complex in Cancer

  2017cites this paper
• Effect of Huisheng oral solution on coagulation function in perioperative period in patients with primary lung cancer.

  2017cites this paper
• Systemic Inflammatory Reaction in Gastric Cancer: Biology and Practical Implications of Neutrophil to Lymphocyte Ratio, Glasgow Prognostic Score and Related Parameters

  2017cites this paper
• Protease-activated receptors - biology and role in cancer.

  2016cites this paper
• Thrombin—unique coagulation system protein with multifaceted impacts on cancer and metastasis

  2016cites this paper
• A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia

  2016cites this paper
• Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancer.

  2015cites this paper
• Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity

  2015cites this paper
• Clotting Factors and Antithrombotic Factors in Selected

  2015cites this paper
• Venous thromboembolism as an essential clinical problem in the group of patients with gynecologic cancer

  2015cites this paper
• Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis

  2015cites this paper
• Clotting Factors and Antithrombotic Factors in Selected Epithelial Malignancies

  2015cites this paper
• Venous thromboembolism in patients with cancer undertaking chemotherapy

  2015cites this paper
• Tumor cell-expressed SerpinB2 is present on microparticles and inhibits metastasis

  2014cites this paper
• Disseminated intravascular coagulation: testing and diagnosis.

  2014cites this paper
• Plasma microparticles in patients with gynaecological malignancy

  2014cites this paper
• Clinical and prognostic significance of coagulation assays in lung cancer.

  2013cites this paper
• IRF-3/STAT1 activation B and enhanced κ tumor-associated macrophages: defective NF- A distinct and unique transcriptional programme expressed by

  2013cites this paper
• Clinical and Prognostic Significance of Coagulation Assays in Gastric Cancer

  2013cites this paper
• Protein Z/protein Z-dependent protease inhibitor system in loco in human gastric cancer

  2013cites this paper
• Protein S: A multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer.

  2013cites this paper
• Prospective study on Clotting Factors in selected non-hematologicalmalignancies.

  2013cites this paper
• Mechanistic Studies On the Role of Polyamines and Microvesicles in Tumor Growth and Hypoxia-mediated Angiogenesis

  2012cites this paper
• Microangiopathic Hemolytic Anemia in 57-year-old Woman with Borderline Serous Tumor of the Ovary: Real-Time Management of Common Pathways of Hemostatic Failure

  2012cites this paper
• Diagnostic criteria and laboratory tests for disseminated intravascular coagulation

  2012cites this paper
• Microangiopathic Hemolytic Anemia in 57-year-old Woman with Borderline Serous Time Management of Common Pathways of Hemostatic

  2012cites this paper
• Protein Z/protein Z-dependent protease inhibitor system in human non-small-cell lung cancer tissue.

  2012cites this paper
• Diagnostic criteria and laboratory tests for disseminated intravascular coagulation.

  2011cites this paper
• Tissue Factor, Blood Coagulation, and Beyond: An Overview

  2011cites this paper
• Expression of protein C (PC), protein S (PS) and thrombomodulin (TM) in human colorectal cancer.

  2010cites this paper
• An overview of coagulation disorders in cancer patients.

  2010influential citation
• The role of plasminogen-plasmin system in cancer.

  2009cites this paper
• Mucosa-associated lymphoid tissue lymphoma of the duodenum together with multiple intra-abdominal thromboses and hepatitis C virus infection: a case report

  2009cites this paper
• Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients.

  2008cites this paper
• The Plasminogen Activator System and Cancer

  2007cites this paper
• Tissue factor expression is a clinical indicator of lymphatic metastasis and poor prognosis in gastric cancer with intestinal phenotype

  2007cites this paper
• Expression of selected coagulation factors in breast cancer within the primary tumor and axillary node metastases

  2007cites this paper
• The Role of Hemostatic System Inhibitors in Malignancy

  2007cites this paper
• The role of hemostatic system inhibitors in malignancy.

  2007cites this paper
• Stroke risk factor, pattern and outcome in patients with cancer

  2006cites this paper
• Thromboembolism in Cancer Patients: Pathogenesis and Treatment

  2006cites this paper
• Hemostatic abnormalities and leukocyte activation caused by infection in patients with malignant lymphoma during chemotherapy.

  2006cites this paper
• Risk Factor, Pattern, Etiology and Outcome in Ischemic Stroke Patients with Cancer: A Nested Case-Control Study

  2006cites this paper
• A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

  2006cites this paper
• Antikoagulation als onkologisches Therapieprinzip

  2005cites this paper
• Venous thromboembolism in patients with cancer and its relationship to the coagulation cascade and vascular endothelial growth factor.

  2005cites this paper
• Clinical study of t-PA and u-PA expression in patients with gastrointestinal cancer

  2005cites this paper
• Hypercoagulant states in malignant lymphoma.

  2005cites this paper
• [Anticoagulation as an oncological therapy principle].

  2005cites this paper
• Haemostatic abnormalities and thrombotic disorders in malignant lymphoma

  2004cites this paper
• Thrombin Inhibitor, Argatroban, Prevents Tumor Cell Migration and Bone Metastasis

  2004cites this paper
• Prothrombin time international normalized ratio monitoring by self-testing

  2004cites this paper
• Contribution of the Hemostatic System to Angiogenesis in Cancer

  2004cites this paper
• Contribution of the hemostatic system to angiogenesis in cancer.

  2004cites this paper